Brain volume is a better biomarker of outcomes in ischemic stroke compared to brain atrophy

Kenda Alhadid,Robert W. Regenhardt,Natalia S. Rost,Markus D. Schirmer

2024-03-19

Abstract:Brain parenchymal fraction (BPF) has been used as a surrogate measure of global brain atrophy, and as a biomarker of brain reserve in studies evaluating clinical outcomes after brain injury. Total brain volume at the time of injury has recently been shown to influence functional outcomes, where larger brain volumes are associated with better outcomes. Here, we assess if brain volume at the time of ischemic stroke injury is a better biomarker of functional outcome than BPF. Acute ischemic stroke cases at a single center between 2003 and 2011, with MR neuroimaging obtained within 48 hours from presentation were eligible. Functional outcomes represented by the modified Rankin Score (mRS) at 90 days post admission (mRS<3 deemed a favorable outcome) were obtained via patient interview or per chart review. Deep learning enabled automated segmentation pipelines were used to calculate brain volume, intracranial volume (ICV), and BPF on the acute neuroimaging data. Patient outcomes were modeled through logistic regressions, and model comparison was conducted using the Bayes Information Criterion (BIC). 467 patients with arterial ischemic stroke were included in the analysis. Median age was 65.8 years, and 65.3% were male. In both models, age and a larger stroke lesion volume were associated with worse functional outcomes. Higher BPF and a larger brain volume were both associated with favorable functional outcomes, however, comparison of both models suggested that the brain volume model (BIC=501) explains the data better compared to the BPF model (BIC=511). The extent of global brain atrophy has been regarded as an important biomarker of post-stroke functional outcomes and resilience to acute injury. Here, we demonstrate that a higher global brain volume at the time of injury better explains favorable functional outcomes, which can be directly clinically assessed.

Neurons and Cognition

What problem does this paper attempt to address?

This paper aims to evaluate whether brain volume in ischemic stroke is a better biomarker for functional prognosis than brain atrophy. The background of the study mentions that brain parenchymal fraction (BPF) is often used as a surrogate marker for global brain atrophy and as a neuroimaging biomarker in evaluating clinical outcomes after brain injury. Despite the influence of natural aging and cardiovascular risk factors on brain volume, recent studies have shown that brain volume at the time of injury may affect functional prognosis, with larger brain volume being generally associated with better prognosis.

The study method involved analyzing MRI neuroimaging data of acute ischemic stroke cases from a single center between 2003 and 2011, calculating brain volume, intracranial volume (ICV), and BPF. Multivariable logistic regression models were used to predict functional outcomes assessed by the modified Rankin Scale (mRS) score at 90 days, and model comparison was performed using the Bayesian Information Criterion (BIC).

The results revealed that older age and larger stroke lesion volume were associated with poorer functional prognosis among the 467 patients. Higher BPF and brain volume were both associated with favorable functional prognosis, but model comparison showed that the brain volume model (BIC=501) provided a better explanation of the data compared to the BPF model (BIC=511).

In conclusion, brain volume at the time of injury, rather than brain atrophy measured by BPF, is a better biomarker for explaining favorable functional prognosis after stroke and can be directly assessed in the clinical setting. This provides a new perspective for understanding and predicting prognosis in stroke patients.